关于艾滋病毒治愈病例的深入思考:我们到底在哪里,未来会发生什么?
Qing Xiao1, Sanxiu He1, Chaoyu Wang1
1Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
Biomolecules
|March 28, 2025
概括
抗逆转录病毒疗法抑制HIV,但不能治愈它,因为病毒储存. 虽然干细胞移植已经导致罕见的艾滋病毒治愈,但免疫治疗和基因编辑等新疗法为艾滋病毒治愈提供了有希望的途径.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 抗逆转录病毒疗法 (ART) 有效地抑制了人类免疫缺陷病毒 (HIV) 复制,但无法消除病毒储备.
- 持续存在的艾滋病毒储存库仍然是实现完全治愈的重大障碍.
- 全球有7例确诊的艾滋病毒治愈病例涉及血性恶性瘤的全源干细胞移植 (allo-HSCT),但确切的机制尚未完全理解.
研究的目的:
- 分析艾滋病毒治愈病例中的治疗方法和成功因素.
- 探索艾滋病毒储存库的性质.
- 讨论艾滋病毒根除的新型治疗策略.
主要方法:
- 审查记录的艾滋病毒治愈病例,特别是那些涉及alo-HSCT.
- 对艾滋病毒储存库的特征和持久性的分析.
- 讨论新兴的艾滋病毒疗法,包括免疫疗法,CAR-T细胞疗法,基因编辑和储备向抗病毒药物.
主要成果:
- 在有限数量的患者中,Allo-HSCT与艾滋病毒根除有关,尽管潜在的机制需要进一步研究.
- 艾滋病毒储存库的持续存在使得完成病毒清除成为一个挑战.
- 新的治疗方法显示出抑制HIV复制的潜力,并可能为未来的治疗策略做出贡献.
结论:
- 虽然allo-HSCT提供了一个潜在的,虽然高风险和依赖于捐赠者的HIV治疗途径,但它不是一个普遍适用的解决方案.
- 了解艾滋病毒储存库对于开发有效的治疗策略至关重要.
- 新兴疗法对推动功能性艾滋病毒治愈的目标具有重大前景.
相关概念视频
Viral Mutations
33.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.0K
Vaccinations
44.1K
Overview
44.1K
Infection
11.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.6K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Human Virome
47
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
47
Vaccines
98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98


